SES AI reaffirms 2026 revenue guidance of $30M-$35M as it targets 1M NDAA-compliant cells per year starting Q4

TransAct outlines $1.5M-$2.0M 2026 adjusted EBITDA outlook while launching strategic review of casino and gaming

2 Services Stocks on Our Watchlist and 1 We Brush Off

3 Healthcare Stocks with Open Questions

3 Semiconductor Stocks That Concern Us